ArriVent BioPharma (AVBP) Q2 2025 Earnings

May 12Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.9
-1.47
-1.03
-0.6

Details

Expected EPS
-0.664
Actual EPS
-1.9
Surprise EPS
-1.24
Surprise Percent
-186.14%

Description

⁨ArriVent BioPharma⁩ (⁦AVBP⁩) has reported earnings of ⁦-1.9⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts